Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹752 Cr₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of GLAND PHARMA is ₹752 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹752 Cr
Mar2025₹2,186 Cr
Mar2024₹-1,560 Cr
Mar2023₹1,587 Cr
Mar2022₹-177 Cr

How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹752 Cr
-65.59
Mar2025 ₹2,186 Cr
Positive
Mar2024 ₹-1,560 Cr
Negative
Mar2023 ₹1,587 Cr
Positive
Mar2022 ₹-177 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹50,735.0 Cr 8.8% 6.2% 57.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8.8%

6.2%

57.7%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses